Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 6, 2004
Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleographyZiane Selmani, Timo Marttila, Ilmari Pyykkö
Journal of Endourology|August 7, 2008
Retrospective analysis of long-term outcomes of 64 patients treated by endopyelotomy in two low-volume hospitals: good and durable resultsMarkku H Vaarala, Timo Marttila, Ilkka Paananen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|October 29, 2009
[Scrotal masses in adulthood]Markku Leskinen, Mika Ala-Lipasti, Timo Marttila, et al.
European Urology Oncology|May 1, 2025
Adjuvant Docetaxel Versus Surveillance in Intermediate- or High-risk Prostate Cancer After Radical Curative Radiotherapy: Final Survival Results from the SPCG-13 TrialPirkko-Liisa Kellokumpu-Lehtinen, Ann-Sofie Fransson, Timo Marttila, et al.
Urology|February 25, 2003
Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancerMarkku J Leskinen, Raija Vainionp, Stina Syrjnen, et al.
The Prostate|March 28, 2003
Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancerMarkku J Leskinen, Kaisu Rantakokko-Jalava, Raija Manninen, et al.
Acta Oncologica (Stockholm, Sweden)|July 18, 2022
2-weekly versus 3-weekly docetaxel for metastatic castration-resistant prostate cancer: complete quality of life results from the randomised, phase-III PROSTY trialMiikka Lehtonen, Jorma Sormunen, Tiina Luukkaala, et al.
European Urology Focus|January 31, 2022
Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 TrialVille Sell, Otto Ettala, Ileana Montoya Perez, et al.
European Urology|April 18, 2016
Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 StudyTimo Marttila, Riikka Järvinen, Tapani Liukkonen, et al.
World Journal of Urology|June 10, 2019
Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trialVille Sell, Otto Ettala, Ileana Montoya Perez, et al.
Pageof 2